Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene

ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene

US Patent 12247078 · Granted Mar 11, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific antibody2025
Generation of binding molecules2025
Generation of binding molecules2025
Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for b2025
Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for b2025
Antibody that binds ErbB-2 and ErbB-32024
Antibody that binds ErbB-2 and ErbB-32024
Antibody that binds ErbB-2 and ErbB-32024
Methods and means for the production of Ig-like molecules2024
Bispecific antibody2024
Bispecific IgG antibodies as T cell engagers2024
Multivalent antibody2024